Full Text View
Tabular View
No Study Results Posted
Related Studies
Brief Eclectic Psychotherapy for PTSD - a Randomized Controlled Trial
This study is currently recruiting participants.
Study NCT00329992   Information provided by University of Zurich
First Received: May 23, 2006   Last Updated: June 2, 2009   History of Changes

May 23, 2006
June 2, 2009
April 2004
May 2009   (final data collection date for primary outcome measure)
PTSD symptom severity (CAPS, Blake et al. 1998; Post-therapy / post-waitlist comparison, controlled for baseline scores [ Time Frame: Last month ] [ Designated as safety issue: No ]
  • PTSD symptom severity (CAPS, Blake et al. 1998)
  • Post-therapy / post-waitlist comparison, controlled for baseline scores, follow-up at 6month post therapy
Complete list of historical versions of study NCT00329992 on ClinicalTrials.gov Archive Site
  • Ability to work and use of health care facilities [ Time Frame: Last months ] [ Designated as safety issue: No ]
  • Comorbidity: Structured Clinical Interview for DSM-IV SCID I (First et al. 1996); Hospital Anxiety and Depression Scale HADS (Zigmond and Snaith 1983) [ Time Frame: Last month ] [ Designated as safety issue: No ]
  • Questions on Life Satisfaction FLZ (Henrich and Herschbach 2000) [ Time Frame: Last month ] [ Designated as safety issue: No ]
  • Posttraumatic Cognitions Inventory PTCI (Foa et al. 1999) [ Time Frame: Last month ] [ Designated as safety issue: No ]
  • Posttraumatic Growth Inventory PGI (Tedeschi and Calhoun 1996) [ Time Frame: Since trauma ] [ Designated as safety issue: No ]
  • EEG, event-related potentials: P300 [ Time Frame: At assessment ] [ Designated as safety issue: No ]
  • Post-therapy / post-waitlist comparison, follow-up at 6month post therapy [ Time Frame: Last month ] [ Designated as safety issue: No ]
  •  Ability to work and use of health care facilities
  •  Comorbidity: Structured Clinical Interview for DSM-IV SCID I (First et al. 1996); Hospital Anxiety and Depression Scale HADS (Zigmond and Snaith 1983)
  •  Questions on Life Satisfaction FLZ (Henrich and Herschbach 2000)
  •  Posttraumatic Cognitions Inventory PTCI (Foa et al. 1999)
  •  Posttraumatic Growth Inventory PGI (Tedeschi and Calhoun 1996)
  •  EEG, event-related potentials: P300
  • Post-therapy / post-waitlist comparison, follow-up at 6month post therapy
 
Brief Eclectic Psychotherapy for PTSD - a Randomized Controlled Trial
Brief Eclectic Psychotherapy for PTSD - a Randomized Controlled Trial

Participants are randomly assigned to either 16 sessions of Brief Eclectic Psychotherapy (Gersons et al. (2000) Journal Trauma Stress 13: 333-348), comprising psychoeducation, exposure, mementos and writing assignments, domain of meaning and integration, farewell ritual, or a minimal attention control group that will be offered 16 sessions of BEP after a waiting time of four months. Participants in the minimal attention control group receive monthly telephone calls and complete a symptom self monitoring diary (Tarrier, N. et al. (1999) Behavior Therapy 30: 597-605) for three weeks.

 
Phase III
Interventional
Treatment, Randomized, Single Blind (Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Chronic Posttraumatic Stress Disorder
Behavioral: Brief Eclectic Psychotherapy for PTSD
  • Experimental: 16 sessions Brief Eclectic Psychotherapy
  • Placebo Comparator: Minimal attention waitlist group
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
40
December 2009
May 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clear memory of an "index" traumatic event (sufficient for constructing a scene to be used in exposure) that occurred no less than six months prior to entering the trial (Montgomery and Bech 2000)
  • PTSD according to the DSM-IV, related to the index traumatic event, as measured with the CAPS: frequency ≥ 1 and intensity ≥ 2 for a symptom to be counted plus a minimum level of overall severity ≥ 50
  • Not receiving other psychotherapy for PTSD during the 16 weeks of active treatment; psychotherapy for other problems, brief check-ins with an existing therapist, and attendance at self-help groups will be allowed
  • If on psychoactive medication: on a stable medication regimen for a minimum of two months prior to entering the trial
  • Aged between 18 and 70 years
  • Sufficient proficiency in the German language to participate in BEP
  • Consent to be randomized into the trial

Exclusion Criteria:

  • Current psychotic, bipolar, substance-related, or severe personality disorder
  • Current severe depressive disorder
  • Severe cognitive impairment or a history of organic mental disorder
  • Evidence of PTSD or depression immediately prior to the index trauma
  • Ongoing threat of traumatic exposure
  • Prominent current suicidal or homicidal ideation
  • Asylum seeking status
Both
18 Years to 70 Years
No
Contact: Lutz Wittmann, MA 0041 (0)44 255 34 09 lutz.wittmann@usz.ch
Switzerland
 
NCT00329992
Prof. Ulrich Schnyder, MD, University Hospital Zurich, Switzerland
3200BO-102204
University of Zurich
  • Swiss National Science Foundation
  • Herrmann-Klaus-Stiftung, Switzerland
  • Olga Mayenfisch Stiftung, Zurich, Switzerland
  • Jubiläumsspende für die Universität Zürich, Switzerland
Principal Investigator: Ulrich Schnyder, MD University of Zurich
Principal Investigator: Lutz Wittmann, MA University of Zurich
University of Zurich
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP